PTC THERAPEUTICS, INC. - Common Stock (PTCT)

Historical Holders from Q1 2014 to Q3 2025

Symbol
PTCT on Nasdaq
CUSIP
69366J200
Type / Class
Equity / Common Stock
Shares outstanding
80.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
82.7M
Holdings value
$5.07B
% of all portfolios
0.005%
Grand Portfolio weight change
+0%
Number of holders
289
Number of buys
152
Number of sells
-141
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PTC THERAPEUTICS, INC. - Common Stock (PTCT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14.8% +85% $892M $422M 11.9M +89.7% BlackRock, Inc. Nov 30, 2025
VANGUARD GROUP INC 10.43% $509M 8.29M The Vanguard Group Sep 30, 2025
ARMISTICE CAPITAL, LLC 6.86% -17.6% $269M -$46.7M 5.43M -14.8% Armistice Capital, LLC Mar 31, 2025
WELLINGTON MANAGEMENT GROUP LLP 6.2% $237M 4.79M Wellington Management Group LLP Dec 31, 2024
Camber Capital Management LP 4.15% $158M 3.2M Camber Capital Management LP Dec 31, 2024

Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 82.7M $5.07B +$182M $61.37 289
2025 Q2 79.9M $3.9B +$45.3M $48.84 280
2025 Q1 78.8M $4.03B +$67.6M $50.96 260
2024 Q4 77.7M $3.51B -$16.7M $45.14 237
2024 Q3 78.8M $2.93B -$39.1M $37.10 200
2024 Q2 79.8M $2.44B -$156M $30.58 197
2024 Q1 85.1M $2.47B +$22.3M $29.09 179
2023 Q4 84.6M $2.33B +$98.7M $27.56 172
2023 Q3 81.1M $1.82B -$70.7M $22.41 177
2023 Q2 81M $3.29B +$98.1M $40.67 202
2023 Q1 78.4M $3.8B +$90.7M $48.44 200
2022 Q4 76.8M $2.93B +$11.6M $38.17 196
2022 Q3 76.1M $3.82B +$84.5M $50.20 200
2022 Q2 74M $2.97B +$15.9M $40.06 172
2022 Q1 73.7M $2.75B -$34.4M $37.31 169
2021 Q4 75.1M $2.99B +$33.2M $39.83 166
2021 Q3 74.2M $2.76B +$31.3M $37.21 173
2021 Q2 73.8M $3.12B +$3.82M $42.27 176
2021 Q1 73.2M $3.46B +$45.8M $47.35 196
2020 Q4 72.8M $4.44B +$101M $61.03 205
2020 Q3 71M $3.32B +$114M $46.75 191
2020 Q2 68.3M $3.45B +$258M $50.74 200
2020 Q1 64.2M $2.86B +$127M $44.61 197
2019 Q4 61M $2.93B +$23.6M $48.03 203
2019 Q3 61.8M $2.09B +$115M $33.82 184
2019 Q2 58.3M $2.62B +$30.2M $45.00 174
2019 Q1 58.6M $2.21B +$374M $37.64 174
2018 Q4 48.8M $1.67B +$32.7M $34.32 164
2018 Q3 46.8M $2.2B +$196M $47.00 179
2018 Q2 42.9M $1.45B +$14.4M $33.73 166
2018 Q1 42.7M $1.15B +$143M $27.06 148
2017 Q4 38.1M $635M +$18.9M $16.68 121
2017 Q3 35.7M $715M +$44.6M $20.01 130
2017 Q2 33.5M $614M +$64.1M $18.33 110
2017 Q1 31.5M $310M +$57.1M $9.84 113
2016 Q4 28.7M $313M -$24.5M $10.91 121
2016 Q3 29.2M $409M +$31.6M $14.01 110
2016 Q2 28.6M $202M -$12.3M $7.02 113
2016 Q1 28.8M $186M -$209M $6.44 111
2015 Q4 36.3M $1.18B +$118M $32.40 141
2015 Q3 32.7M $873M -$30.3M $26.70 154
2015 Q2 32.3M $1.55B +$36.9M $48.13 151
2015 Q1 31.4M $1.91B +$209M $60.85 159
2014 Q4 28.4M $1.47B +$199M $51.77 132
2014 Q3 24.4M $1.07B +$72.7M $44.01 99
2014 Q2 23M $600M +$12.3K $26.14 83
2014 Q1 23M $600M +$217M $26.14 64